314 related articles for article (PubMed ID: 25677464)
1. Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts.
Parize P; Hamelin A; Veziris N; Morand PC; Guillemain R; Lortholary O; Dupin N
J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):101-5. PubMed ID: 25677464
[TBL] [Abstract][Full Text] [Related]
2. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient.
Tebas P; Sultan F; Wallace RJ; Fraser V
Clin Infect Dis; 1995 Feb; 20(2):443-4. PubMed ID: 7742453
[TBL] [Abstract][Full Text] [Related]
3. Emergence of resistance to clarithromycin during treatment of disseminated cutaneous Mycobacterium chelonae infection: case report and literature review.
Vemulapalli RK; Cantey JR; Steed LL; Knapp TL; Thielman NM
J Infect; 2001 Oct; 43(3):163-8. PubMed ID: 11798252
[TBL] [Abstract][Full Text] [Related]
4. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae.
Wallace RJ; Tanner D; Brennan PJ; Brown BA
Ann Intern Med; 1993 Sep; 119(6):482-6. PubMed ID: 8357113
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin.
Zahid MA; Klotz SA; Goldstein E; Bartholomew W
Clin Infect Dis; 1994 Jun; 18(6):999-1001. PubMed ID: 8086568
[TBL] [Abstract][Full Text] [Related]
6. Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection.
Driscoll MS; Tyring SK
J Am Acad Dermatol; 1997 Mar; 36(3 Pt 1):495-6. PubMed ID: 9091495
[No Abstract] [Full Text] [Related]
7. Disseminated cutaneous Mycobacterium chelonae infection in an immunocompetent host.
Halpern J; Biswas A; Cadwgan A; Tan BB
Clin Exp Dermatol; 2010 Apr; 35(3):269-71. PubMed ID: 20500199
[TBL] [Abstract][Full Text] [Related]
8. Case of disseminated cutaneous Mycobacterium chelonae infection mimicking cutaneous vasculitis.
Ichihara A; Jinnin M; Fukushima S; Inoue Y; Ihn H
J Dermatol; 2014 May; 41(5):414-7. PubMed ID: 24801916
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium chelonae infection successfully treated with oral clarithromycin and linezolid.
Kyle SD; Porter WM
Br J Dermatol; 2004 Nov; 151(5):1101. PubMed ID: 15541095
[No Abstract] [Full Text] [Related]
10. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Gui J; Wang F; Hong CY; Li JL; Liang J
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
[TBL] [Abstract][Full Text] [Related]
11. In vitro bactericidal activity of antibiotic combinations against clinical isolates of Mycobacterium chelonae.
Cremades R; Santos A; Rodríguez JC; Garcia-Pachon E; Ruiz M; Royo G
J Chemother; 2008 Feb; 20(1):43-7. PubMed ID: 18343742
[TBL] [Abstract][Full Text] [Related]
12. Disseminated cutaneous Mycobacterium chelonae infection.
Kane CL; Vincent AL; Greene JN; Sandin RL
Cancer Control; 2000; 7(2):181-4. PubMed ID: 10783823
[No Abstract] [Full Text] [Related]
13. [Development of subcutaneous nodules after mesotherapy].
Ramos A; Roustan G; Lucena JL; Daza RM
Enferm Infecc Microbiol Clin; 2011 Dec; 29(10):775-7. PubMed ID: 21722998
[No Abstract] [Full Text] [Related]
14. Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection.
Little JS; Dedrick RM; Freeman KG; Cristinziano M; Smith BE; Benson CA; Jhaveri TA; Baden LR; Solomon DA; Hatfull GF
Nat Commun; 2022 May; 13(1):2313. PubMed ID: 35504908
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous Mycobacterium chelonae infection presenting as symmetrical plaques on both shins in an immunocompetent patient.
Chung WK; Kim MS; Kim CH; Lee MW; Choi JH; Moon KC; Koh JK
Acta Derm Venereol; 2009 Nov; 89(6):663-4. PubMed ID: 19997711
[No Abstract] [Full Text] [Related]
16. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
Hyon JY; Joo MJ; Hose S; Sinha D; Dick JD; O'Brien TP
Arch Ophthalmol; 2004 Aug; 122(8):1166-9. PubMed ID: 15302657
[TBL] [Abstract][Full Text] [Related]
17. [Mycobacterium chelonae cutaneous infection: efficacy of prolonged treatment by clarithromycin].
Bordet AL; Machet L; De Muret A; François-Ramanantsoa C; Lorette G; Vaillant L
Ann Dermatol Venereol; 1997; 124(3):251-3. PubMed ID: 9686059
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Mycobacterium chelonae-induced skin infection with clarithromycin.
Franck N; Cabié A; Villette B; Amor B; Lessana-Leibowitch M; Escande JP
J Am Acad Dermatol; 1993 Jun; 28(6):1019-21. PubMed ID: 8496448
[No Abstract] [Full Text] [Related]
19. Mycobacterium chelonae: nonhealing leg ulcers treated successfully with an oral antibiotic.
Terry S; Timothy NH; Zurlo JJ; Manders EK
J Am Board Fam Pract; 2001; 14(6):457-61. PubMed ID: 11757889
[TBL] [Abstract][Full Text] [Related]
20. A surgical wound infection due to Mycobacterium chelonae successfully treated with clarithromycin.
Saluja A; Peters NT; Lowe L; Johnson TM
Dermatol Surg; 1997 Jul; 23(7):539-43. PubMed ID: 9236871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
